F. Daniel

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

Sheela Rao, David Cunningham, Robert E. Hawkins et al. · British Journal of Cancer · 2005 · 141 citations · Full text

Medicine, Oncology, Pharmacology +8

Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL 2 trial

David Cunningham, Sujaya Rao, Naureen Starling et al. · Journal of Clinical Oncology · 2006 · 108 citations

Medicine, Oncology, Pharmacology +15

A phase II trial of marimastat in advanced pancreatic cancer

James D. Evans, Andrew Stark, C D Johnson et al. · British Journal of Cancer · 2001 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

John Primrose, Harry Bleiberg, F. Daniel et al. · British Journal of Cancer · 1999 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications

Pippa Corrie, Ravi Bulusu, Charles B. Wilson et al. · British Journal of Cancer · 2012 · 39 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17